Instituto Rosenbusch S.A. (BCBA:ROSE)
156.00
-4.00 (-2.50%)
At close: Aug 14, 2026
Instituto Rosenbusch Income Statement
Financials in millions ARS. Fiscal year is April - March.
Millions ARS. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| 1,456 | 6,404 | 1,380 | 10,886 | 9,860 | |
Revenue Growth | -77.27% | 364.13% | -87.33% | 10.40% | 130.61% |
Cost of Revenue | 1,788 | 6,690 | 1,581 | 5,905 | 7,036 |
Gross Profit | -332.06 | -286.03 | -201.14 | 4,980 | 2,825 |
Selling, General & Admin | 692.01 | 2,449 | 436.31 | 2,428 | 2,517 |
Other Operating Expenses | 163.94 | 634.37 | -9.3 | 91.5 | 273.17 |
Operating Expenses | 855.95 | 3,083 | 427.01 | 2,520 | 2,790 |
Operating Income | -1,188 | -3,369 | -628.15 | 2,461 | 34.37 |
Interest Expense | - | -1,651 | - | -822.99 | -1,058 |
Interest & Investment Income | - | 0.23 | - | - | - |
Currency Exchange Gain (Loss) | 333.58 | 556.45 | -165.59 | -3,504 | 1,709 |
Other Non Operating Income (Expenses) | 388.12 | - | 11.27 | 0 | - |
EBT Excluding Unusual Items | -466.3 | -4,463 | -782.47 | -1,866 | 684.84 |
Gain (Loss) on Sale of Assets | - | - | - | - | 686.65 |
Pretax Income | -466.3 | -4,463 | -782.47 | -1,866 | 1,371 |
Income Tax Expense | - | 50.87 | - | 245.29 | 134.85 |
Earnings From Continuing Operations | -466.3 | -4,514 | -782.47 | -2,112 | 1,237 |
Minority Interest in Earnings | - | -83.74 | - | 247.16 | -10.76 |
Net Income | -466.3 | -4,598 | -782.47 | -1,864 | 1,226 |
Net Income to Common | -466.3 | -4,598 | -782.47 | -1,864 | 1,226 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | - | 43 | - | 43 | 43 |
Shares Outstanding (Diluted) | - | 43 | - | 43 | 43 |
Shares Change | - | - | - | - | - |
EPS (Basic) | - | -107.95 | - | -43.78 | 28.78 |
EPS (Diluted) | - | -107.95 | - | -43.78 | 28.78 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -1,891 | 397.75 | -299.65 | 706.67 | 215.92 |
Free Cash Flow Per Share | - | 9.34 | - | 16.59 | 5.07 |
Gross Margin | -22.81% | -4.47% | -14.58% | 45.75% | 28.65% |
Operating Margin | -81.61% | -52.61% | -45.53% | 22.61% | 0.35% |
Profit Margin | -32.03% | -71.80% | -56.71% | -17.13% | 12.43% |
Free Cash Flow Margin | -129.88% | 6.21% | -21.72% | 6.49% | 2.19% |
EBITDA | -1,165 | -3,177 | -572.92 | 2,621 | 141.25 |
EBITDA Margin | -80.01% | -49.61% | -41.52% | 24.08% | 1.43% |
D&A For EBITDA | 23.19 | 192.08 | 55.23 | 160.55 | 106.89 |
EBIT | -1,188 | -3,369 | -628.15 | 2,461 | 34.37 |
EBIT Margin | -81.61% | -52.61% | -45.53% | 22.61% | 0.35% |
Effective Tax Rate | - | - | - | - | 9.83% |
Advertising Expenses | - | 10.51 | - | 16.7 | 21.43 |